Home » Topics » Regulatory

Regulatory
RSS

FDA approves Remeron SolTab for treatment of depression

Jan. 17, 2001

UCB's nonsedating antihistamine approved in Germany

Jan. 16, 2001

Nutropin Depot development expanded by Genentech and Alkermes

Jan. 15, 2001

Preclinical studies further define effects underlying tranilast's efficacy in preventing restenosis

Jan. 15, 2001

Provalis obtains U.K. marketing rights to Pennsaid topical solution

Jan. 12, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Expanded phase III trial program in bipolar disorder announced for Seroquel

Jan. 10, 2001

Argatroban sNDA filed for HIT patients undergoing PCI

Jan. 10, 2001

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Jan. 8, 2001

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...